ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
批准号:
2269793
负责人:
VALERIE ASKANAS
金额:
$6.88万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-04-01 至 1996-03-31
关键词:
Alzheimer's disease aging amyloid proteins animal tissue biopsy cytotoxicity gene expression histopathology human subject human tissue immunoelectron microscopy in situ hybridization innervation laboratory rat mixed tissue /cell culture muscle muscle necrosis myositis neuromuscular junction northern blottings phenotype synapses transmission electron microscopy western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal is based on our new findings that Alzheimer-like
beta-amyloid protein betaAP is abnormally accumulated in vacuolated
muscle fibers of patients with Sporadic (S) and Hereditary (H)
Inclusion-Body Myositis (IBM). Heretofore, abnormalities in the brain
involving betaAP accumulation were considered exclusive for Alzheimer's
disease, Down syndrome, Dutch-type hereditary cerebrovascular amyloidosis
and very advanced age. betaAP expression in normal and diseased human
muscle has not been studied.
The broad objective of our research is to utilize human muscle
tissue-culture models for multidisciplinary molecular biology studies of
the role of betaAP and its precursor protein (betaAPP). The long-term
goals are to ascertain the role of betaAP in human muscle during: a)
muscle necrosis; b) normal development, maturity and aging; c)
development and maintenance of neuromuscular synapses.
Specific Aims: 1. Establish whether betaAP will be abnormally accumulated
in cultured muscle fibers of patients with a hereditary and sporadic IBM
(in both betaAP is accumulated in the biopsied muscle). 2. Delineate
whether development in culture of the morphologic phenotype
characteristic of IBM correlates with an abnormal accumulation of betaAP
and other betaAPP sequences. 3. Establish in cultured IBM muscle the
sequence of developmental expression of the betaAPP gene, and
accumulation of betaAP and possibly other betaAPP sequences. 4. Establish
whether exogenously applied betaAP is toxic to cultured normal human
muscle.
This study is expected to establish whether: a) abnormal accumulation of
betaAP in H-IBM is genetically determined; b) there is increased
expression of the betaAPP gene in cultured H-IBM muscle; c) betaAP is
toxic to human muscle and whether it produces the IBM phenotype.
Because the pathologic accumulation of betaAP in IBM muscle and in AD
brain have many similar features, their pathogeneses may share similar
mechanisms. It is possible that the characteristic muscle degeneration
occurring in IBM may represent a specific form of muscle aging, with
similarities to brain aging in the Alzheimer phenotype. Accordingly,
detailed molecular studies of pathogenic mechanisms in the more readily
accessible biopsied living IBM muscle (as compared to brain), including
use of cultured H-IBM muscle, might contribute to understanding AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6448889
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2001
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6353435
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2000
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6318249
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2000
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6295391
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:2837339
-
项目类别:
-
资助金额:$23.04万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6948644
-
项目类别:
-
资助金额:$1.8万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6884632
-
项目类别:
-
资助金额:$31.28万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6098054
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6509651
-
项目类别:
-
资助金额:$33.84万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6294141
-
项目类别:
-
资助金额:$3.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6629838
-
项目类别:
-
资助金额:$34.85万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6720867
-
项目类别:
-
资助金额:$31.27万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6372344
-
项目类别:
-
资助金额:$32.88万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6168924
-
项目类别:
-
资助金额:$23.72万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6295383
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
-
批准号:2609681
-
项目类别:
-
资助金额:$26.73万
-
财政年份:1995
-
负责人:VALERIE ASKANAS
-
依托单位:
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
-
批准号:2273225
-
项目类别:
-
资助金额:$19.86万
-
财政年份:1995
-
负责人:VALERIE ASKANAS
-
依托单位:
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
-
批准号:2037950
-
项目类别:
-
资助金额:$20.68万
-
财政年份:1995
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
-
批准号:2269794
-
项目类别:
-
资助金额:$7.19万
-
财政年份:1993
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
-
批准号:3418751
-
项目类别:
-
资助金额:$6.6万
-
财政年份:1993
-
负责人:VALERIE ASKANAS
-
依托单位:
海外基金